Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.

Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.

Promyelocytic leukemia-retinoic acid receptor alpha (PML-RARα) expression in acute promyelocytic leukemia (APL) impairs transforming growth factor beta (TGFβ) signaling, leading to cell growth advantage. Halofuginone (HF), a low-molecular-weight alkaloid that modulates TGFβ signaling, was used to tr...

Full description

Bibliographic Details
Main Authors:	Lorena L de Figueiredo-Pontes, Patricia A Assis, Bárbara A A Santana-Lemos, Rafael H Jácomo, Ana Sílvia G Lima, Aglair B Garcia, Carolina H Thomé, Amélia G Araújo, Rodrigo A Panepucci, Marco A Zago, Arnon Nagler, Roberto P Falcão, Eduardo M Rego
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3203897?pdf=render

Similar Items

Halofuginone — The Multifaceted Molecule
by: Mark Pines, et al.
Published: (2015-01-01)

Coagulation abnormalities in acute promyelocytic leukemia Alterações da coagulação associadas à leucemia promielocítica aguda
by: Rafael H. Jacomo, et al.
Published: (2009-08-01)

Halofuginone Inhibits Angiogenesis and Growth in Implanted Metastatic Rat Brain Tumor Model-an MRI Study
by: Rinat Abramovitch, et al.
Published: (2004-09-01)

Inhibition of Neovascularization and Tumor Growth, Facilitation of Wound Repair, by Halofuginone, an Inhibitor of Collagen Type I Synthesis
by: Rinat Abramovitch, et al.
Published: (1999-10-01)

Abomasitis associated with halofuginone intoxication in pre-weaned calves
by: Wouter van Mol, et al.
Published: (2024-01-01)

Transcriptome profile of halofuginone resistant and sensitive strains of Eimeria tenella
by: Pei Sun, et al.
Published: (2023-03-01)

Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
by: Mark A. Tye, et al.
Published: (2022-08-01)

Halofuginone for cancer treatment: A systematic review of efficacy and molecular mechanisms
by: Li Mi, et al.
Published: (2022-11-01)

A Novel Synthesis of the Efficient Anti-Coccidial Drug Halofuginone Hydrobromide
by: Junren Zhang, et al.
Published: (2017-06-01)

Microarray profiling reveals the integrated stress response is activated by halofuginone in mammary epithelial cells
by: Kuo Winston P, et al.
Published: (2011-10-01)

The anti- proliferative effects of Ferulago angulata on human promyelocytic leukemia cell line (HL-60)
by: zahra Rezaei dezaki, et al.
Published: (2019-09-01)

Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis
by: Jain, V, et al.
Published: (2015)

Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy
by: Sharon Mordechay, et al.
Published: (2021-06-01)

Effects of corticosteroids vs halofuginone on vocal fold wound healing in an ovine model
by: Jacqueline Allen
Published: (2021-08-01)

PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA HAS EXCELLENT RESULTS WITH AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
by: ACRD Bronzoni, et al.
Published: (2023-10-01)

Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells
by: Zuo R, et al.
Published: (2021-02-01)

Halofuginone prevents outer retinal degeneration in a mouse model of light-induced retinopathy
by: Yukihiro Miwa, et al.
Published: (2024-01-01)

EtcPRSMut as a molecular marker of halofuginone resistance in Eimeria tenella and Toxoplasma gondii
by: Pei Sun, et al.
Published: (2023-04-01)

Chimiothérapie des theilérioses bovines par un anticoccidien, l'halofuginone. Note préliminaire
by: Gerrit Uilenberg, et al.
Published: (1980-01-01)

Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage
by: Wenbo Mu, et al.
Published: (2018-03-01)

Safety and efficacy of STENOROL® (halofuginone hydrobromide) as a feed additive for chickens for fattening and turkeys
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2020-11-01)

Development of monoclonal antibody-based colloidal gold immunochromatographic assay for analysis of halofuginone in milk
by: Shanshan Song, et al.
Published: (2019-01-01)

Treatment for acute promyelocytic leukemia during pregnancy
by: V V Troitskaia, et al.
Published: (2013-10-01)

History of Acute Promyelocytic Leukemia
by: Miguel A. Sanz, et al.
Published: (2021-07-01)

Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
by: Sarah Cristina Bassi, et al.
Published: (2012-01-01)

Halofuginone-coated urethral catheters prevent periurethral spongiofibrosis in a rat model of urethral injury
by: Sean P. Elliott
Published: (2011-02-01)

Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition
by: Danièle Taras, et al.
Published: (2006-04-01)

Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors Síndrome da diferenciação na leucemia promielocítica aguda: patogênese e fatores de risco
by: Eduardo M. Rego, et al.
Published: (2008-06-01)

Halofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial Cells.
by: Tony L H Chu, et al.
Published: (2015-01-01)

Differentiation syndrome in patients with acute promyelocytic leukemia
by: Nusiba H. Elamin, et al.
Published: (2023-01-01)

Halofuginone inhibits tumor migration and invasion by affecting cancer-associated fibroblasts in oral squamous cell carcinoma
by: Danni Wang, et al.
Published: (2022-11-01)

Amino acid response by Halofuginone in Cancer cells triggers autophagy through proteasome degradation of mTOR
by: Carlo Follo, et al.
Published: (2019-05-01)

DIFFERENTIATION SYNDROME IN PROMYELOCYTIC LEUKEMIA : CLINICAL PRESENTATION, PATHOGENESIS AND TREATMENT
by: Eduardo Magalhães Rego, et al.
Published: (2011-10-01)

Enantiodivergent Synthesis of Halofuginone by Candida antarctica Lipase B (CAL-B)-Catalyzed Kinetic Resolution in Cyclopentyl Methyl Ether (CPME)
by: Elisa De Marchi, et al.
Published: (2021-06-01)

Theranostic mesoporous platinum nanoplatform delivers halofuginone to remodel extracellular matrix of breast cancer without systematic toxicity
by: Jie Zhang, et al.
Published: (2023-07-01)

Safety of a feed additive consisting of halofuginone hydrobromide (STENOROL®) for chickens for fattening and turkeys (Huvepharma N.V.)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2022-12-01)

Acute Promyelocytic Leukemia
by: Xavier Thomas, et al.
Published: (2020-12-01)

Auer “rhombuses”: The unusual cytomorphology of acute promyelocytic leukemia
by: Vasily Ovechko, et al.
Published: (2023-02-01)

Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia.
by: Gerson Hiroshi Yoshinari, et al.
Published: (2019-01-01)

History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies
by: Pierre Bercier, et al.
Published: (2024-03-01)